{
    "symbol": "PHR",
    "quarter": 3,
    "year": 2022,
    "date": "2021-12-09 14:22:04",
    "content": " I think we've been thinking about this market for years, and it's like we believe sort of the, the relationship between payers, providers and life sciences continues to be blurred and we are very excited to have capabilities that and the team that we bring with us to help complement a lot of the investments we've been making and we think the Insignia we're going to, that's something we've been thinking about for years and we're really excited."
}